Evidence map›Paper›PMID 20515656›Full record

ArticleBiochemical and biophysical research communications2010

Copper inhibits P2Y(2)-dependent Ca(2+) signaling through the effects on thapsigargin-sensitive Ca(2+) stores in HTC hepatoma cells.

Svjetlana Dolovcak, Shar L Waldrop, J Gregory Fitz, Gordan Kilic

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Svjetlana DolovcakDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9151, USA.
Shar L Waldrop
J Gregory Fitz
Gordan Kilic
The University of Texas Southwestern Medical Center · US

Funding

Regulation of Secretion by Bile Duct Epithelial CellsR37DK046082 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI FITZ, JOHN GREGORY · 2002 to 2012
$3.3M
REGULATION OF SECRETION BY BILE DUCT EPITHELIAL CELLSR01DK046082 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI FITZ, JOHN G. · 1993 to 2001
$383k
NIDDK NIH HHS DK46082NIDDK NIH HHS R01 DK046082NIDDK NIH HHS R37 DK046082
6 · The paper itself

Abstract

Purinergic P2Y(2) G-protein coupled receptors play a key role in the regulation of hepatic Ca(2+) signaling by extracellular ATP. The concentration of copper in serum is about 20muM. Since copper accumulates in the liver in certain disease states, the purpose of these studies was to assess the effects of copper on P2Y(2) receptors in a model liver cell line. Exposure to a P2Y(2) agonist UTP increased [Ca(2+)](i) by stimulating Ca(2+) release from thapsigargin-sensitive Ca(2+) stores. Pretreatment of HTC cells for several minutes with copper did not affect cell viability, but potently inhibited increases in [Ca(2+)](i) evoked by UTP and thapsigargin. During this pretreatment, copper was not transported into the cytosol, and inhibited P2Y(2) receptors in a concentration-dependent manner with the IC(50) of about 15muM. These results suggest that copper inhibits P2Y(2) receptors through the effects on thapsigargin-sensitive Ca(2+) stores by acting from an extracellular side. Further experiments indicated that these effect of copper may lead to inhibition of regulatory volume decrease (RVD) evoked by hypotonic solution. Thus, copper may contribute to defective regulation of purinergic signaling and liver cell volume in diseases associated with the increased serum copper concentration.

Indexed as

Calcium SignalingAnimalsCalciumCell Line, TumorCopperInhibitory Concentration 50LiverPurinergic P2 Receptor AntagonistsRatsReceptors, Purinergic P2Receptors, Purinergic P2Y2ThapsigarginCalciumCopperPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2Receptors, Purinergic P2Y2Thapsigargin

Identifiers

PMID20515656
PMCPMC2899700
OpenAlexW2089244711

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.